Pages that link to "Q73783320"
Jump to navigation
Jump to search
The following pages link to Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like) (Q73783320):
Displaying 38 items.
- ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma (Q21129306) (← links)
- Anaplastic lymphoma kinase: signalling in development and disease (Q24312329) (← links)
- Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: identification of a new TFG-ALK(XL) chimeric gene with transforming activity (Q24669845) (← links)
- Novel mRNA-containing cytoplasmic granules in ALK-transformed cells (Q30498700) (← links)
- NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma (Q30831857) (← links)
- Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression (Q34013976) (← links)
- KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only (Q34162787) (← links)
- Anaplastic large-cell lymphoma with atypical chromosomal translocation t(2;5) and hypophyseal tumor (Q34271002) (← links)
- Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors (Q34564071) (← links)
- Molecular genetics of pediatric soft tissue tumors: clinical application (Q35183100) (← links)
- Molecular pathology in the diagnosis and treatment of non-Hodgkin's lymphomas. (Q35644667) (← links)
- Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage (Q35746987) (← links)
- Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor (Q35747060) (← links)
- The role of molecular pathology in non-small-cell lung carcinoma-now and in the future (Q36040599) (← links)
- ALK-immunoreactive neoplasms. (Q36092957) (← links)
- Diffuse large B-cell lymphomas with plasmablastic differentiation (Q36223630) (← links)
- The cellular functions of clathrin (Q36478282) (← links)
- Clinical relevance of molecular genetics to paediatric sarcomas (Q36806186) (← links)
- Adult systemic anaplastic large-cell lymphoma: recommendations for diagnosis and management (Q36926529) (← links)
- Translocations in epithelial cancers (Q37363960) (← links)
- Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma. (Q37644788) (← links)
- Tyrosine kinase gene fusions in cancer: translating mechanisms into targeted therapies (Q37919976) (← links)
- Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology (Q38141512) (← links)
- Novel ALK inhibitors in clinical use and development. (Q38427240) (← links)
- Molecular genetics of childhood, adolescent and young adult non-Hodgkin lymphoma. (Q38771110) (← links)
- Targeting ALK: Precision Medicine Takes on Drug Resistance (Q39103431) (← links)
- Clathrin heavy chain gene fusions expressed in human cancers: analysis of cellular functions (Q41807334) (← links)
- The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells (Q41927054) (← links)
- Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies. (Q41942675) (← links)
- NPM-ALK: The Prototypic Member of a Family of Oncogenic Fusion Tyrosine Kinases. (Q42254184) (← links)
- Aberrant ALK tyrosine kinase signaling. Different cellular lineages, common oncogenic mechanisms (Q42857007) (← links)
- Tyrosine phosphorylation in human lymphomas. (Q44661433) (← links)
- Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects. (Q48528844) (← links)
- Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes. (Q52679023) (← links)
- The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL). (Q54117760) (← links)
- Discovery Stories of RET Fusions in Lung Cancer: A Mini-Review (Q64075678) (← links)
- Central nervous system relapse in a pediatric anaplastic large cell lymphoma patient with CLTC/ALK translocation treated with alectinib: A case report (Q95264166) (← links)
- Diagnostic Capability of Next-Generation Sequencing Fusion Analysis in Identifying a Rare CASE of TRAF1-ALK-Associated Anaplastic Large Cell Lymphoma (Q95841197) (← links)